Drug recall · July 23, 2025
Levothyroxine Sodium Tablets recall
Why: Subpotent Drug: Assay below the approved specification
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-451-17
- Lots / codes
Lot #D2300092, Exp Date: 12/31/2025; Lot #D2400722, Exp Date: 03/31/2026
- Quantity
- 9,739 bottles
- Company
- Accord Healthcare, Inc., Raleigh, NC
- Distribution
- Nationwide in the USA
- Initiated
- June 20, 2025 · Voluntary: Firm initiated
- Classified
- July 14, 2025
- Reported
- July 23, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levothyroxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.